MedTrace Logo

Systemic Lupus Erythematous and Heart Conduction Disorders

NCT02162992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2019-10-28

Study results available
· View outcomes & findings →

Summary

Connective tissue diseases have been related to heart conduction disorders. The anti-Ro/SSA antibodies are thought to have a pathogenic role, and they most prevalent in systemic lupus erythematous (SLE). The aim of this study is to evaluate the relationship between SLE, arrhythmias and its serologic profile.

Conditions

  • Lupus Erythematosus, Systemic
  • Atrioventricular Block
  • Sudden Death

Interventions

OTHER

No intervention

Observational

Sponsors & Collaborators

  • Germans Trias i Pujol Hospital

    lead OTHER

Principal Investigators

  • Roger Villuendas · GTIPUH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2017-11-30
Completion
2018-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02162992 on ClinicalTrials.gov